Browse by all authors Browse By Author Name - Duffull,+S.+B.

Browse Results (62 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 2

Result Pages:    1 2  next › last »

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2002). Abbreviated AUC for monitoring tacrolimus in liver transplant recipients. In: Proceedings of Australian Health & Medical Research Congress 2002. AHMRC 2002, Melbourne, (2107-2107). 24-29 Nov. 2002. 256  
Isbister, G. K., Friberg, L. E., Stokes, B., Buckley, N. A., Lee, C., Gunja, N., Brown, S. G., MacDonald, E., Graudins, A., Hoidgate, A. and Duffull, S. B. (2007) Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Annals of Emergency Medicine, 50 5: 593-600. doi:10.1016/j.annemergmed.2007.03.009 74   20 Cited 23 times in Scopus23 0
McGree, J. M., Drovandi, C. C., Thompson, M. H., Eccleston, J. A., Duffull, S. B., Mengersen, K., Pettitt, A. N. and Goggin, T. (2012) Adaptive Bayesian compound designs for dose finding studies. Journal of Statistical Planning and Inference, 142 6: 1480-1492. doi:10.1016/j.jspi.2011.12.029 60   4 Cited 5 times in Scopus5 0
Hennig, S., Wainwright, C. E., Bell, S., Miller, H., Charles, B. G. and Duffull, S. B. (2006). A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis. In: PAGE: Abstracts of the Annual Meeting of the Population Approach Group in Europe. 15th Annual Meeting of the Population Approach Group in Europe, Bruges, Belgium, (). 14-16 June 2006. 141  
Tanos, P. P., Isbister, G. K., Lalloo, D. G., Kirkpatrick, C. M. J. and Duffull, S. B. (2008) A model for venom-induced consumptive coagulopathy in snake bite. Toxicon, 52 7: 769-780. doi:10.1016/j.toxicon.2008.08.013 258   18 Cited 19 times in Scopus19 0
Dansirikul, C., Duffull, S. B., Morris, R. and Tett, S.E. (2004). An argument for dose individualisation of sirolimus in renal transplant recipients. In: Warwick P. Anderson, 8th World Conference on Clinical Pharmacology & Therapeutics 2004 - Abstracts. CPT2004, Brisbane, (60-60). 1-6 Aug 2004. doi:10.1111/j.1440-1681.2004.v31_i11_abs.x 51   0
Stickland, M. D., Kirkpatrick, C., Begg, E., Duffull, S. B., Oddie, S. J. and Darlow, B. (2001) An extended interval dosing method for gentamicin in neonates. Journal of Antimicrobial Chemotherapy, 48 6: 887-893. doi:10.1093/jac/48.6.887 115   25 0
Evans, N. D., Godfrey, K. R., Chapman, M. J., Chappell, M. J., Aarons, L. and Duffull, S. B. (2001) An identifiability analysis of a parent-metabolite pharmacokinetic model for ivabradine.. Journal of Pharmacokinetics & Pharmacodynamics, 28 1: 93-105. doi:10.1023/A:1011521819898 125   15 Cited 3 times in Scopus3 0
Duffull, S. B., Chabaud, S., Nony, P., Laveille, C., Girard, P. and Aarons, L. (2000) A pharmacokinetic simulation model for ivabradine in healthy volunteers. European Journal of Pharmaceutical Sciences, 10 10: 285-294. doi:10.1016/S0928-0987(00)00086-5 66   23 Cited 30 times in Scopus30 0
Feng, Y., Green, B., Duffull, S. B., Kane, S. L., Bobek, M. B. and Bies, R. R. (2005). Application of Monte Carlo simulations to identify an appropriate dosage strategy for patients receiving a continuous intravenous infusion of enoxaparin. In: C. M. Stein, Clinical Pharmacology & Therapeutics. 2005 Annual Meeting of American Society for Clinical Pharmacology & Therapeutics, Orlando, USA, (P88-P88). 2-6 March 2005. doi:10.1016/j.clpt.2004.12.230 54   0 0
Duffull, S. B., Eccleston, J. A., Redmann, S. and Waterhouse, T. H. (2004). A real time optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics. In: PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe. Annual Meeting of the Population Approach Group in Europe, Uppsala, Sweden, (). 17-18 June 2004. 29  
Duffull, S. B., Waterhouse, T. H., Redmann, S. and Eccleston, J. A. (2004). A real time optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics. In: Population Approach Group in Europe - Thirteenth Meeting. Population Approach Group in Europe - Thirteenth Meeting (PAGE 2004), Uppsala University, Sweden, (42-42). 17-18 June 2004. 75  
Chan, A. S. Y., Isbister, G. K., Kirkpatrick, C. M. J. and Duffull, S. B. (2008) Assessing risk of a prolonged QT interval-a survey of emergency physicians. International Journal of Emergency Medicine, 1 1: 35-41. doi:10.1007/s12245-008-0014-6 201   0
Dansirikul, C., Friberg, L. E., Duffull, S. B., Morris, R. and Tett, S.E. (2004). Bayesian population pharmacokinetic analysis of sirolimus. In: Population Approach Group in Europe - Thirteenth Meeting. Population Approach Group in Europe - Thirteenth Meeting (PAGE), Uppsala University, Sweden, (23-23). 17-18 June 2004. 116  
Monteleone, J. and Duffull, S. B. (2003). Choice of Best Design. In H.C. Kimko and S.B. Duffull (Ed.), Simulation for Designing Clinical Trials: A Pharmacokinetic-Pharmacodynamic Modeling Perspective 1 ed. (pp. 173-200) New York: Marcel Dekker. 52  
McGree, J. M., Eccleston, J. A. and Duffull, S. B. (2008) Compound Optimal Design Criteria for Nonlinear Models. Journal of Biopharmaceutical Statistics, 18 4: 646-661. doi:10.1080/10543400802071352 48   12 Cited 14 times in Scopus14 0
Duffull, S. B. and Tett, S. E. (2001) Concepts for critical appraisal of an original research paper.. Australian Journal of Hospital Pharmacy, 31 3: 200-205. 284  
Dansirikul, C., Choi, M. and Duffull, S. B. (2002). Conversion of non-compartmental to compartmental pharmacokinetics: Proof of concept study. In: PAGANZ 02. PAGANZ 4th Annual Scientific Meeting, Melbourne, (1-1). 28-30 Jan. 2002. 174  
Denman, N. G., McGree, J. M., Eccleston, J. A. and Duffull, S. B. (2011) Design of experiments for bivariate binary responses modelled by Copula functions. Computational Statistics and Data Analysis, 55 4: 1509-1520. doi:10.1016/j.csda.2010.07.025 39   0 Cited 1 times in Scopus1 0
Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Detecting drug interactions associated with tacrolimus. In: A. McLachlan, PAWS & PAGANZ. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., (2-2). 19-21 Feb. 2003. 48  
Retout, S., Duffull, S. B. and Mentre, F. (2001) Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs.. Computer Methods & Programs in Biomedicine, 65 2: 141-151. doi:10.1016/S0169-2607(00)00117-6 88   87 Cited 91 times in Scopus91 0
Kirkpatrick, C., Strickland, M., Begg, E. and Duffull, S. B. (2000). Development and testing of an extended interval dosing nomogram for gentamicin in neonates. In: W. C. Hodgson and R. E. Loicano, Proceedings of ASCEPT. Joint Meeting of ASCEPT and the British Pharmacological Society, Monash University, Melbourne, (150-150). 3-6 Dec 2000. 97  
Roos, J. F., Kirkpatrick, C. M. J., Tett, S. E., MaLachlan, A. J. and Duffull, S. B. (2008) Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infection. British Journal of Clinical Pharmacology, 66 4: 455-466. doi:10.1111/j.1365-2125.2008.03247.x 87   8 Cited 8 times in Scopus8 0
Roos, J. F., Tett, S. E., Kirkpatrick, C. M. J. and Duffull, S. B. (2007). Development of a sufficient design for parameter estimation of fluconazole population pharmacokinetics in HIV patients. In: PAGANZ 07: Population Approach Group in Australia & New Zealand, Singapore, (). 13-15 February 2007. 75  
Han, P. Y., Duffull, S. B., Kirkpatrick, C. M. J. and Green, B. (2007) Dosing in obesity: A simple solution to a big problem. Clinical Pharmacology & Therapeutics, 82 5: 505-508. doi:10.1038/sj.clpt.2007.6100381 113   80 Cited 91 times in Scopus91 0
Chan, A., Isbister, G. K., Kirkpatrick, C. M. J. and Duffull, S. B. (2007) Drug-induced QT prolongation and torsades de pointes: Evaluation of a QT nomogram. QJM: An International Journal of Medicine, 100 10: 609-615. doi:10.1093/qjmed/hcm072 230   59 Cited 68 times in Scopus68 13
Duffull, S. B. (2000) Drugs and food: Clinically significant interactions. New Ethicals Journal, 3 2: 43-47. 35  
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. In: Abstracts of the Annual Meeting of the Population Approach Group in Europe. Population Approach Group in Europe (PAGE) Conference, Marseille, France, (). June 2008. 29  
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008) Individualized compared with conventional dosing of enoxaparin. Clinical Pharmacology & Therapeutics, 83 6: 882-888. doi:10.1038/sj.clpt.6100399 83   17 Cited 24 times in Scopus24 0
Kimko, H. and Duffull, S. B. (2003). Introduction to Simulation for Design of Clinical Trials. In H.C. Kimko and S.B. Duffull (Ed.), Simulation for Designing Clinical Trials: A Pharmacokinetic-Pharmacodynamic Modeling Perspective 1 ed. (pp. 1-16) New York: Marcel Dekker. 80  
Tan, S., Wyse, B. D., Duffull, S. B. and Smith, M. T. (2005). Investigation of temporal changes in the anti-allodynic effectiveness of chronically administered gabapentin in a rat model of neuropathic pain. In: Abstract book of 11th World Congress on Pain. 11th World Congress on Pain, Sydney, (74-P51). 21-26 August 2005. 41  
Isbister, G.K., Friberg, L. E., Hackett, L.P. and Duffull, S. B. (2005). Is there value in pharmacokinetic-pharmacodynamic modeling of overdose patients? The example of citalopram and QT prolongation. In: E.A. Davis and C.G. Sobey, Program & Abstracts: Joint Meeting of ASCEPT and APSA 2005. Joint Meeting of ASCEPT & APSA, Melbourne, Victoria, (103). 4-7 Dec. 2005. 70  
Janmahasatian, S., Duffull, S. B., Chagnac, A., Kirkpatrick, C. M.J. and Green, B. (2008) Lean body mass normalizes the effect of obesity on renal function. British Journal of Clinical Pharmacology, 65 6: 964-965. doi:10.1111/j.1365-2125.2008.03112.x 63   28 Cited 31 times in Scopus31 1
Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Limited sampling strategies for monitoring tacrolimus in liver transplant recipients. In: A. McLachlan, 5th Annual PAWS & PAGANZ Scientific Meeting. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., (1-1). 19-21 Feb. 2003. 38  
Green, B., Duffull, S. B., Cottrell, N. and D'Emden, M. (2000). MI: The type two tale. In: Proceedings of SHPA Biennial Clinical Conference. SHPA Biennial Clinical Conference, Gold Coast, (28-28). 20-22 Oct. 2000. 33  
Nestorov, I., Graham, G. G., Aarons, L. and Duffull, S. B. (2003). Model-based Integration for Clinical Trial Simulation and Design: A Phase ll Case Study for Naratriptan. In H.C. Kimko and S.B. Duffull (Ed.), Simulation for Designing Clinical Trials: A Pharmacokinetic-Pharmacodynamic Modeling Perspective 1 ed. (pp. 313-325) New York: Marcel Dekker. 82  
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2009) Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. British Journal of Clinical Pharmacology, 68 5: 700-711. doi:10.1111/j.1365-2125.2009.03518.x 83   8 Cited 11 times in Scopus11 0
Waterhouse, T. H., Eccleston, J. A. and Duffull, S. B. (2004). On optimal design for discrimination and estimation. In: J. Antoch, Compstat 2004 - Proceedings In Computational Statistics. Compstat 2004, Prague, Czech Republic, (1963-1970). 23-27 August, 2004. 71  
Waterhouse, T. H., Eccleston, J. A. and Duffull, S. B. (2006) Optimal crossover designs for logistic regression models in pharmacodynamics. Journal of Biopharmaceutical Statistics, 16 6: 881-894. doi:10.1080/10543400600851880 94   5 Cited 4 times in Scopus4 0
Waterhouse, T. H., Eccleston, J. A. and Duffull, S. B. (2009) Optimal Design Criteria for Discrimination and Estimation in Nonlinear Models. Journal of Biopharmaceutical Statistics, 19 2: 386-402. doi:10.1080/10543400802677257 55   11 Cited 12 times in Scopus12 0
Duffull, S. B., Eccleston, J. A., Redmann, S. and Waterhouse, T. H. (2004). Optimal design for model discrimination and estimation with multiple responses. In: International Biometric Conference and Australian Statistical Conference, Carins, (). 11-16 July 2004. 17  
Waterhouse, T. H., Redmann, S., Duffull, S. B. and Eccleston, J. A. (2005) Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patients. Journal of Pharmacokinetics And Pharmacodynamics, 32 3-4: 521-545. doi:10.1007/s10928-005-0026-2 64   27 Cited 27 times in Scopus27 0
Duffull, S. B., Mentre, F. and Aarons, L. (2001) Optimal design of a population pharmacodynamic experiment for ivabradine.. Pharmaceutical Research, 18 1: 83-89. doi:10.1023/A:1011035028755 43   34 Cited 34 times in Scopus34 0
McGree, J., Duffull, S. B., Eccleston, J. A. and Ward, L. C. (2006). Optimal designs for measuring bioimpedance - design for nonlinear mixed effects models (G5). In: Designed Experiments: Recent Advances in Methods and Applications. Designed Experiments: Recent Advances in Methods and Applications, Southampton, (Abstract). 7-10 Sept, 2006. 66  
McGree, J. M., Duffull, S. B., Eccleston, J. A. and Ward, L. C. (2006). Optimal designs for studying bioimpedance. In: Royal Statistical Society 2006 Conference. Royal Statistical Society 2006 Conference, Belfast, (Abstract). 10-14 Sept, 2006. 53  
McGree, J. M., Duffull, S. B., Eccleston, J. A. and Ward, L. C. (2007) Optimal designs for studying bioimpedance. Physiological Measurement, 28 12: 1465-1483. doi:10.1088/0967-3334/28/12/002 54   4 Cited 5 times in Scopus5 0
Staatz, C. E., Dansirikul, C., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2003). Pharmacodynamic investigations of tacrolimus in liver transplantation. In: The Transplantation Society of Australia & New Zealand 21st Annual Scientific Meeting. TSANZ 21st Annual Scientific Meeting, Canberra, (63-63). 9-11 April 2003. doi:10.1046/j.1440-1711.2003.00812.x 39   0
Friberg, L. E., Isbister, G. K. and Duffull, S. B. (2006) Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. British Journal of Clinical Pharmacology, 61 2: 177-190. doi:10.1111/j.1365-2125.2005.02546.x 123   41 Cited 47 times in Scopus47 0
Kirkpatrick, C. M. J., Duffull, S. B., Barclay, M. L., Patton, N., Moore, G. A. and Doogue, M. P. (2004). Population pharmacokinetic analysis of high-dose oral busulphan for bone marrow transplant in adults and children. In: Proceedings of the 13th Meeting Population Approach Group in Europe. 13th Meeting Population Approach Group in Europe (PAGE 2004), Uppsala University, Sweden, (63-63). 17-18 June, 2004. 53  
Friberg, L. E., Isbister, G.K., Dawson, A.H., Hackett, L.P., Whyte, I. M. and Duffull, S. B. (2004). Population pharmacokinetic modelling of citalopram taken in overdose. In: Warwick P. Anderson, 8th World Conference on Clinical Pharmacology & Therapeutics 2004 - Abstracts. CPT2004, Brisbane, (174-174). 1-6 Aug 2004. 92  

Page 1 of 2

Result Pages:    1 2  next › last »